Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]propanamide (1:1) manufacturers
- R-932348 choline
-
- $1980.00
-
2026-07-27
- CAS:1620142-65-5
- Purity:
- Supply Ability: 10g
|
| | Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]propanamide (1:1) Basic information |
| | Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]propanamide (1:1) Chemical Properties |
| | Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]propanamide (1:1) Usage And Synthesis |
| Uses | R-348 (R-932348) choline is a potent and orally active JAK3 and Syk inhibitor. R-348 reduces IFN-γ, IL-6, and IL-10 expression. R-348 effectively diminishes acute cardiac allograft rejection[1]. | | IC 50 | JAK3; IL-6; IL-10 | | References | [1] Deuse T, et al. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection. Transplantation. 2008 Mar 27;85(6):885-92. DOI:10.1097/TP.0b013e318166acc4 |
| | Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]propanamide (1:1) Preparation Products And Raw materials |
|